Mela Sciences (NSDQ:Mela) said today that it agreed to purchased PhotoMedex’s (NSDQ:PHMD) Xtrac and Vtrac laser business assets for $42.5 million. Xtrac and Vtrac are devices used to treat psoriasis, vitiligo and other skin diseases, the company said. “This is a transformational event for Mela Sciences. As a result of this acquisition, Mela becomes a multi-product […]
PhotoMedex Inc.
Edwards Lifesciences insiders keep selling | Wall Street Beat
Edwards Lifesciences (NYSE:EW) insiders aren’t buying, and they haven’t been for several months, according to a report.
Although insiders have been selling shares, 3 of them in the last week, none have purchased any since at least April, SeekingAlpha reported.
By the numbers: The aesthetic medical device market picks up during the 2nd quarter
The market for aesthetic medical devices gained some ground during the 2nd quarter, a MassDevice.com analysis shows, although healthy sales growth didn’t necessarily translate into healthy bottom lines for all comers.
University of Michigan sues St. Jude Medical for breach of contract
The University of Michigan is suing St. Jude Medical (NYSE:STJ), accusing the medical device maker of failing to pay $4.3 million in royalties on sales of St. Jude’s Epic and Trifecta cardiovascular valves.
Varian and Siemens launch global radiosurgery deal | Wall Street Beat
Biolase CEO Pignatelli touts $1 salary | Earnings Roundup
Biolase Technology (NSDQ:BLTI) CEO Federico Pignatelli agreed to another year at a $1 salary as the dental laser maker met Wall Street’s 4th-quarter forecast with a whopping 35% top-line bump.
Pignatelli set his annual pay package at $1 and 35,000 shares of BLTI stock when he took the role of vice chairman in July 2010, a month after he was terminated as president, SEC filings show.
Baxter inks $325M buyout pact with Synovis | Acquisitions Roundup
Baxter International Inc. (NYSE:BAX) agreed to pony up $28 per share, or $325 million, for Synovis Life Technologies, Inc. (NSDQ:SYNO) and its lines of soft tissue repair and microsurgery products.
News of the deal sent SYNO shares up nearly 49 percent to $27.78 from yesterday’s close. BAX shares ticked up 0.3 percent to $49.93 as of about noon today.
Biomet sees slight sales increase as losses widen | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Medtronic touts heart failure treatment study | Research roundup
Medtronic Inc. (NYSE:MDT) said results from the Improve HF study demonstrate that select guideline-based outpatient heart failure measures can increase patient survival and might be useful for improving patient quality of care.
The Improve HF (The Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting) study is the largest U.S.-based outpatient heart failure clinical study. The results of the study were published in the journal Circulation.
